Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14
Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14
复制标题
DOI：
10.1016/j.jsxm.2017.05.018
复制
发表时间：
2017-12-01
影响因子：
3.5
通讯作者：
Shifrin, Jan L.
中科院分区：
文献类型：
--
作者：
Kingsberg, Sheryl A.;Althof, Stanley;Shifrin, Jan L.
自千年以来，我们目睹了女性性功能障碍（FSD）的科学和治疗方面的重大进步。这一进展包括：（i）发展新的理论模型来描述女性健康和功能失调的性反应;（ii）女性性功能障碍的替代分类策略;（iii）大脑、激素、心理和人际关系研究的重大进展，重点是病因因素和治疗方法;（iv）对FSD的强有力和有效的公众宣传;（iv）对女性性功能障碍的研究。和（v）提高对女性及其伴侣FSD影响的教育意识。目的：回顾文献，描述评估和治疗女性性欲减退障碍、女性性唤起障碍和女性性高潮障碍的最佳实践。方法：该委员会对文献进行了全面的审查，并在他们之间进行了讨论，以确定最佳的评估和治疗方法。委员会从生物心理社会透镜的角度提出建议，（证据等级）用于评估和治疗性欲减退障碍、女性性唤起障碍和女性性高潮障碍。结论：在这篇文章中回顾了自上次国际性医学咨询会出版物以来发生的许多重大进展。虽然证据支持一个综合的生物心理社会的方法来评估和治疗这些疾病，生物和心理因素被人为分离的审查目的。我们认识到，当临床医生和患者共同努力识别和解决所有相关因素时，可以实现最佳结果（总和大于其部分的总和）。
Introduction: Since the millennium we have witnessed significant strides in the science and treatment of female sexual dysfunction (FSD). This forward progress has included (i) the development of new theoretical models to describe healthy and dysfunctional sexual responses in women; (ii) alternative classification strategies of female sexual disorders; (iii) major advances in brain, hormonal, psychological, and interpersonal research focusing on etiologic factors and treatment approaches; (iv) strong and effective public advocacy for FSD; and (v) greater educational awareness of the impact of FSD on the woman and her partner.Aims: To review the literature and describe the best practices for assessing and treating women with hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders.Methods: The committee undertook a comprehensive review of the literature and discussion among themselves to determine the best assessment and treatment methods.Results: Using a biopsychosocial lens, the committee presents recommendations (with levels of evidence) for assessment and treatment of hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders.Conclusion: The numerous significant strides in FSD that have occurred since the previous International Consultation of Sexual Medicine publications are reviewed in this article. Although evidence supports an integrated biopsychosocial approach to assessment and treatment of these disorders, the biological and psychological factors are artificially separated for review purposes. We recognize that best outcomes are achieved when all relevant factors are identified and addressed by the clinician and patient working together in concert (the sum is greater than the whole of its parts).